Teladoc Health, Inc. (TDOC)
NYSE: TDOC · IEX Real-Time Price · USD
12.30
-0.43 (-3.38%)
At close: May 20, 2024, 4:00 PM
12.20
-0.10 (-0.81%)
After-hours: May 20, 2024, 5:38 PM EDT
Teladoc Health Revenue
Teladoc Health had revenue of $2.62B in the twelve months ending March 31, 2024, with 6.01% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $646.13M with 2.68% year-over-year growth. In the year 2023, Teladoc Health had annual revenue of $2.60B with 8.13% growth.
Revenue (ttm)
$2.62B
Revenue Growth
+6.01%
P/S Ratio
0.80
Revenue / Employee
$467,733
Employees
5,600
Market Cap
2.09B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.60B | 195.58M | 8.13% |
Dec 31, 2022 | 2.41B | 374.13M | 18.41% |
Dec 31, 2021 | 2.03B | 938.75M | 85.81% |
Dec 31, 2020 | 1.09B | 540.66M | 97.71% |
Dec 31, 2019 | 553.31M | 135.40M | 32.40% |
Dec 31, 2018 | 417.91M | 184.63M | 79.14% |
Dec 31, 2017 | 233.28M | 110.12M | 89.42% |
Dec 31, 2016 | 123.16M | 45.77M | 59.15% |
Dec 31, 2015 | 77.38M | 33.86M | 77.78% |
Dec 31, 2014 | 43.53M | 23.62M | 118.67% |
Dec 31, 2013 | 19.91M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
agilon health | 4.78B |
AMN Healthcare Services | 3.48B |
Amneal Pharmaceuticals | 2.50B |
Integra LifeSciences Holdings | 1.53B |
Premier | 1.34B |
Amphastar Pharmaceuticals | 676.21M |
STAAR Surgical Company | 326.24M |
ADMA Biologics | 283.18M |
TDOC News
- 9 hours ago - Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 16, 2024 in Teladoc Health, Inc. Lawsuit - TDOC - Accesswire
- 1 day ago - Teladoc Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 16, 2024 to Discuss Your Rights - TDOC - Accesswire
- 1 day ago - Investors who lost money on Teladoc Health, Inc.(TDOC) should contact Levi & Korsinsky about pending Class Action - TDOC - Accesswire
- 2 days ago - TDOC INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Teladoc Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
- 3 days ago - Levi & Korsinsky Reminds Shareholders of an Investigation into Teladoc Health, Inc. (TDOC) Regarding Potential Securities Fraud Allegations - Accesswire
- 4 days ago - Investors who lost money on Teladoc Health, Inc. should contact Levi & Korsinsky about an ongoing investigation - TDOC - Accesswire
- 5 days ago - Teladoc Health, Inc. (TDOC) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - Accesswire
- 6 days ago - Levi & Korsinsky Announces an Investigation on Behalf of Teladoc Health, Inc. (TDOC) Shareholders Who May Have Been Affected by Fraud - Accesswire